PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,295,588
|
comparison breast cancer cervic cancer uzbekistan korea first report uzbekistan korea oncolog consortium general countri economi educ level life expect increas incid cancer increas peak incid cancer occur individu health proport non communic diseas increas develop live environ chang diet lifestyl enhanc method detect contribut increas cancer incid well recent uzbekistan grown rapid incid cancer also increas health manag cancer treatment also identif prevent caus effect screen consid south korea common ethnic uzbekistan success perform nation screen seven major cancer past year year surviv rate cancer diagnosi korea year ago recent improv form advisori consortium oncologist uzbekistan korea could cooper cancer manag uzbekistan advisori consortium intend present necessari consider recommend cancer manag uzbekistan examin literatur cancer statist uzbekistan south korea addit overal analysi identifi review major cancer high morbid three categori uzbekistan gynecolog cancer breast cervic cancer cancer common men lung liver cancer gastrointestin cancer stomach colorect cancer review cover general cancer statist uzbekistan detail review gynecolog cancer two countri relev recommend
|
D002583;D001943
|
T191
|
36,295,587
|
new apheresi devic antithrombot drug remov pump coronari arteri bypass surgeri background object hemoadsorpt devic cytosorb cytosorb inc princeton nj usa shown effici remov ticagrelor whole blood vitro promis clinic experi made integr hemoadsorpt cartridg cardiopulmonari bypass cpb circuit cardiac surgeri reduc advers event materi method report describ novel approach use new apheresi platform pur nikkisio co ltd tokyo japan use extracorpor circuit cytosorb could instal remov ticagrelor pump coronari arteri bypass opcab procedur result year old male index case coronari arteri diseas dual antiplatelet therapi hemoadsorpt initi skin incis opcab surgeri continu min elimin ticagrelor blood volum circul cytosorb l total thus far treatment strategi use four case chd dapt need opcab surgeri intraop postop cours unev patient devic relat advers event occur conclus combin pur apheresi pump hemoadsorpt cytosorb column opcab procedur appear safe effect elimin antiplatelet drug
|
D047549;D001781
|
T061
|
36,295,586
|
novel techniqu treatment metaphys void proxim humerus fractur elder patient background object treatment proxim humerus fractur elder patient challeng report high complic rate most relat implant failur involv screw cut penetr metaphys defect common osteoporot bone weaken osteosynthesi construct novel techniqu augment polymethylmethacryl pmma bone cement develop treatment patient advanc age complex proxim humerus fractur metaphys void wherebi cement allow partial cure min mix achiev medium viscos manual place defect traumat later window volum ml per patient aim retrospect clinic studi assess techniqu versus autolog bone graft augment augment materi method outcom patient plate neer three four part fractur assign group case augment bone graft augment cement augment assess studi dash cs pain score rang motion analyz month statist analysi perform factor treatment age group neer fractur type follow period consider age covari result dash cs improv follow cement augment three six month compar bone graft signific correct age covari p age group signific effect score worsen valu higher age non augment graft patient p case cement augment patient p cement augment demonstr good clinic result month mean dash mean cs percentag versus contralater side signific differ among techniqu p despit cement augment group repres older popul four part fractur concern advers event specif relat novel techniqu conclus studi detail novel techniqu treatment metaphys defect pmma cement augment elder patient complex proxim humerus fractur follow one year wherebi cement allow partial cure achiev medium viscos manual place defect traumat later window result demonstr clinic equival short term result month compar augment bone graft augment despit patient group older higher rate sever fractur pattern techniqu appear safe specif relat advers event ad surgeon armamentarium treatment difficult manag fractur
|
D001843;D012784
|
T122;T037
|
36,295,585
|
genet environment effect develop white matter hyperintens middl age twin popul introduct white matter hyperintens wmh indic white matter brain lesion magnet reson imag mri use marker brain age cerebrovascular neurodegen disord twin studi reveal substanti uniform wmh herit elder twin object studi investig genet environment compon wmh well import healthi twin popul util mri scanner middl age twin popul method brain mri perform healthi adult twin hungarian twin registri scanner monozygot mz dizygot dz twin median age year femal male count wmh flair imag calcul use autom volumetri pipelin volbrain human process age sex adjust mz dz intra pair correl determin total varianc decompos genet share uniqu environment compon use structur equat model result age sex adjust mz intrapair correl higher dz correl indic moder genet influenc lesion rmz rdz total count rmz rdz deep white matter count rmz rdz infratentori count rmz rdz cerebellar count rmz rdz periventricular count indic moder herit respect rest varianc influenc uniqu environment effect e respect conclus number wmh lesion moder influenc genet effect particular infratentori region middl age twin result suggest distribut wmh various brain region heterogen
|
D014430;D066127
|
T099;T024;T023
|
36,295,584
|
prognost abil pre post treatment inflammatori marker oral squamous cell carcinoma stepwis model background object studi examin import inflammatori marker treatment prognost oscc avail inform post therapi inflammatori marker prognost signific limit studi aim evalu prognost abil pre post treatment inflammatori marker patient oscc materi method retrospect analysi inform oscc patient socio demograph clinico patholog recurr metastasi surviv data gather clinic record multivari cox proport hazard regress stepwis model conduct identifi prognost predictor os dfs multivari model perform evalu use harrel concord statist result os high pre treatment lmr hr ci high post treatment plc hr ci plr hr ci indic poor prognosi dfs high pre treatment sii hr ci high post treatment plc hr ci plr hr ci associ increas mortal fit os dfs stepwis cox regress model proven time depend auc respect conclus high pre treatment level lmr sii high post treatment level plc plr independ predictor poor prognosi patient oscc
|
D009062;D002294;D006258
|
T191
|
36,295,583
|
system endotheli function plasma xanthin oxidoreductas activ blood pressur variabl patient stabl coronari arteri diseas background object although previous studi show activ xanthin oxidoreductas xor rate limit enzym purin metabol beyond serum uric acid level associ develop coronari arteri diseas cad under mechan unclear endotheli dysfunct greater blood pressur bp variabl may play role investig relat among endotheli function xor bp variabl materi method post hoc studi use pool data patient stabl cad two prospect investig system endotheli function assess reactiv hyperemia index rhi xor activ measur bp variabl evalu use bp measur three four day hospit result total patient stabl cad undergo percutan coronari intervent includ patient system endotheli dysfunct rhi lt multivari analysi identifi higher bodi mass index bmi femal gender diabet factor associ endotheli dysfunct higher bmi also relat elev xor activ addit current smoke signific correl observ rhi xor activ similar hospit bp variabl associ neither endotheli function xor conclus among patient stabl cad sever factor identifi associ system endotheli dysfunct elev xor activ howev direct relat endotheli function xor bp variabl found
|
D014968;D003324
|
T047;T126;T116
|
36,295,582
|
parenchyma spare liver resect regen liver surgeri way go liver resect malign tumor respect oncolog margin ensur safeti improv qualiti life therefor tumor stage under liver diseas perform status attent assess decis process concept parenchyma spare liver surgeri nowaday use altern major hepatectomi address deepli locat lesion intric topographi mean complex multiplanar parenchyma spare liver resect prefer guidanc intraop ultrasound regen liver surgeri evolv liver growth induct method increas resect stimul hypertrophi parenchyma intend remain resect refer futur liver remnant achiev portal vein embol liver venous depriv intervent approach portal vein ligat associ liver partit portal vein ligat stage hepatectomi surgic techniqu interest although strategi conceptu origin eventu becam caught never end parenchyma spare liver surgeri vs regen liver surgeri debat howev strategi valid must master use increas resect opinion consid parenchyma spare liver surgeri along techniqu complex liver resect intraop ultrasound guidanc prefer strategi treat liver tumor addit liver volum manipul regen surgeri employ resect need extend beyond possibl parenchyma spare liver surgeri
|
D006498;D011788
|
T061;T078
|
36,295,581
|
combin hyperbar oxygen therapi oral steroid treatment sudden sensorineur hear loss earli late background object sever treatment avail sudden sensorineur hear loss ssnhl studi compar differ treatment base delay onset diseas studi aim compar effect hyperbar oxygen therapi hbot oral steroid os combin therapi hbot os treat ssnhl materi method random studi analyz patient ssnhl patient evalu pure tone audiometri test pta baselin day treatment three group avail hbot os b hbot os c baselin pta patient random assign group statist analysi perform one way anova chi squar result patient hbot os hbot group improv auditori function p lt hbot best choic treatment start day ssnhl onset hbot os case late treatment profound snhl recov equal hbot hbot os p lt upslop snhl obtain better auditori result hbot compar hbot os p lt downslop flat ssnhl improv hbot os compar hbot p lt conclus combin hbot os valid treatment ssnhl case earli late treatment combin hbot os choic best result case treatment start gt day symptom onset
|
D006931;D003639;D006319
|
T061;T184;T033;T047
|
36,295,580
|
implic misinform stigma age relat qualiti life depress cope mechan adult patient psoriasi background object stigma lack accept societi might detriment effect qualiti life patient psoriasi sometim compar chronic diseas condit affect appear patient burn therefor survey patient diagnos psoriasi determin implic misinform stigma qualiti life depress cope strategi stratifi differ age categori materi method cross section studi design sampl size minimum patient consid preval psoriasi general popul studi particip patient control given paper base unstandard questionnair onlin version three standard survey cohort patient split three age group determin age relat qualiti life cope mechan result proport patient histori depress depress symptom among patient psoriasi signific higher multipl discrep observ patient control regard question target stigma misinform cope orient problem experienc inventori cope questionnair older patient like use posit cope mechan engag problem focus cope young patient use emot focus cope mechan howev patient age rang group score highest physic mental health among particip fill item short form survey sf survey dermatolog life qualiti index dlqi result show signific patient answer lot much concern embarrass social activ sexual difficulti affect older patient strongest correl depress observ young patient group believ psoriasi caus skin cancer rho sexual difficulti rho embarrass rho evalu dlqi survey year old group strongest correl feel stigmat rho sexual difficulti rho disengag cope style rho conclus respond reason well inform regard psoriasi degre stigma remain like due involuntari emot respons repuls embarrass essenti establish initi aim educ general public rais awar establish toler social environ psoriasi patient
|
D011788;D011565
|
T078;T047
|
36,295,579
|
impact capsulotomi hip biomechan arthroscopi background object anterior capsulotomi routin perform hip arthroscopi improv joint visual howev part complet disrupt stabil ligament hip studi aim report effect convent extens arthroscop capsulotomi hip stabil materi method eight fresh frozen cadaver pelvis use studi rang motion translat measur compar among differ capsular condit util hip arthroscopi special interest iliofemor ligament ifl zona orbiculari zo condit includ intact capsul interport capsulotomi capsulotomi complet ifl disrupt complet ifl zo disrupt intern rotat three flexion plane extern rotat six flexion plane measur correspond femor head translat distanc applic nm torqu result compar intact capsul signific increas extern rotat observ interport capsulotomi capsulotomi flexion signific translat observ capsulotomi rang mm across flexion angl compar convent interport capsulotomi disrupt entir ifl result signific increas extern rotat flexion plane signific translat accompani disrupt zo conclus interport capsulotomi result increas rang motion capsulotomi lead signific translat partial complet tear ifl zo result extern rotat translat
|
D001182;D009140
|
T060;T047;T061
|
36,295,578
|
itga gene polymorph associ type diabet mellitus kazakhstan popul background object nowaday everi tenth adult world suffer diabet mellitus dm diabet retinopathi dr common microvascular complic type dm tdm lead caus acquir blind middl age individu mani countri previous studi identifi associ sever gene polymorph suscept microvascular complic dm various worldwid popul studi aim test hypothesi associ singl nucleotid polymorph snp vegf id rage tc ta tcfl rs itga bglii gene predisposit dr among tdm patient kazakhstan popul materi method conduct case control studi compar genotyp distribut allel frequenc group dr patient n diabet patient without dr n healthi control n genotyp identifi use pcr rflp method result case genotyp distribut correspond hardi weinberg equilibrium group diabet patient without dr signific differ genotyp distribut snps studi differ group diabet patient healthi control four five snps also signific time group diabet patient differ signific healthi control genotyp distribut p respect allel frequenc p respect bglii polymorph itga gene adjust multipl comparison differ group diabet patient without dr control group remain signific pbonf genotyp pbonf allel bglii allel associ diabet dr patient diabet patient without dr associ also observ subset kazakh conclus studi show bglii polymorph itga gene associ tdm dr accord data risk allel diabet wild bglii allel minor bglii consid riski dr
|
D003924;D003930
|
T047
|
36,295,577
|
gait analysi bilater knee osteoarthr correl western ontario mcmaster univers osteoarthr index assess background object object accur intuit evalu knee joint function patient knee osteoarthr koa import studi aim clarifi gait characterist patient bilater koa correl western ontario mcmaster univers osteoarthr index womac materi method patient bilater koa condit match healthi individu enrol experiment control group respect footscan coda motion gait analysi system use analys gait paramet gait spatiotempor paramet knee joint motion paramet collect weight bear balanc walk stabil assess use discret trend relev gait indic patient experiment group evalu use womac pearson correl analysi perform gait data womac score data experiment group result veloc cadenc step length stride length experiment group signific lower control group p lt step time gait cycl signific greater experiment group control group p lt total stanc doubl stanc time experiment group signific greater control group p lt wherea singl stanc time shorter control group p lt rang motion maximum flexion angl experiment group signific lower control group p lt minimum angl knee extens greater control group p lt discret trend weight bear balanc walk stabil gait index experiment group greater control group womac score gait analysi signific correl p lt conclus gait function patient koa signific wors normal peopl womac scale gait analysi use assess koa sever differ perspect good consist
|
D020370
|
T047
|
36,295,576
|
comprehens evalu minim invas achill tendon reconstruct hamstr graft indic satisfactori long term outcom background object achill tendon largest tendon bodi vulner injuri limit blood suppli combin forc subject given relev achill tendon proper function foot ankl primari goal present studi use holist approach comprehens evalu achill tendon reconstruct result multipl level materi method studi design follow way patient partial total achill tendon tear subject minim invas achill tendon reconstruct patient subject clinic function isokinet test month treatment clinic evalu includ calf circumfer measur subject patient report test atr eq l vas scale function evalu base three test weight bear lung test heel rise test singl leg hop isometr isokinet evalu perform use biodex dynamomet result calf circumfer oper limb signific lower non oper limb month surgic procedur howev improv second evalu subject outcom improv signific month surgeri signific better result function oper limb also obtain month surgeri howev muscl strength paramet oper limb alreadi compar non oper one month surgeri compar two evalu time conclus overal result extens evalu high satisfactori patient return normal physic activ medic point view assum heal process complet month surgeri howev import result indic consid heal process rehabilit process separ
|
D000125;D013708;D000070633
|
T023;T037
|
36,295,575
|
treatment complex two vessel coronari heart diseas singl left intern mammari arteri graft retrospect doubl center analysi short term outcom background object strategi revascular may constrain patient insuffici bypass graft increas risk wound heal disord among complex left side doubl vessel diseas percutan coronari intervent pci well surgic procedur minim invas coronari arteri bypass graft via left minithoracotomi mic cabg treatment option cabg use left intern mammari arteri graft may effect treatment strategi materi method review data patient treat cologn tuebingen includ patient receiv left intern mammari arteri lima graft addit graft lima object focus intraop short term outcom result total patient treat lima lima graft procedur fowler score calcul total patient lack venous graft materi due prior vein strip patient present sever vein varicosi overal distal anastomos target vessel left anterior descend diagon intermedi branch andor left margin ramus perform part sequenti mean flow lima left anterior descend lad anastomosi mlmin mean pi mean flow subsequ graft account mlmin mean pi median hospit stay day incid postop wound heal disord observ patient discharg one day readmiss diagnosi pericardi effus day mortal within cohort conclus patient requir surgic myocardi revascular due complex two vessel coronari arteri diseas cad easili manag lima alon despit elev fowler score promis outcom prospect studi need conduct well longer term surveil substanti benchmark long term result well patenc rate
|
D008323;D003324;D062645
|
T061;T023;T047
|
36,295,574
|
associ polymorph gene encod antioxid enzym gpx rs sod rs transcript factor nrf rs risk develop prostat cancer background object mount evid implic oxid damag prostat carcinogenesi contribut modif macromolecul drive cellular malign transform function singl nucleotid polymorph snps enzym involv redox homeostasi disrupt pro oxid antioxid balanc lead accumul reactiv oxygen speci oxid damag investig potenti role genet polymorph antioxid enzym glutathion peroxidas gpx rs superoxid dismutas sod rs regulatori antioxid protein nuclear factor erythroid relat factor nrf rs suscept prostat cancer develop pc prognosi materi method conduct case control studi consist patient pc control gene polymorph determin quantit polymeras chain reaction qpcr polymeras chain reaction confront two pair primer pcr cttp method multipl risk model compos inspect separ mutual effect multipl gene combin acquir contributori factor risk pc develop result independ carrier least one sod c allel increas risk pc develop signific amplifi advanc statist model test combin individu sod c allel nrf cc genotyp also increas risk pc develop augment combin acquir contributori factor mean month follow investig gene polymorph affect overal surviv conclus result suggest gene polymorph could use risk biomark pc evolut
|
D000975;D011471
|
T123;T121;T191;T039;T044
|
36,295,573
|
medium term outcom tvt abbrevo treatment stress urinari incontin efficaci safeti year follow background object stress urinari incontin sui common type urinari incontin affect approxim adult women failur conserv treatment mid urethr sling mus consid effect safe surgic procedur sui waltregni et al introduc new tran obtur tension free vagin tape tvt procedur name tvt abbrevo tvt aim present studi evalu efficaci safeti tvt procedur women pure sui year follow materi method women complain pure sui symptom concomit urodynam stress incontin usi prospect enrol treat tvt procedur postop subject outcom measur includ intern consult incontin questionnair short form ici q sf patient global impress improv pgi scale patient degre satisfact scale pgi score patient satisfact score use defin subject success object success defin absenc urin leakag cough stress test advers event collect accord clavien dindo classif follow result univari analysi use investig outcom fifti women met inclus criteria underw tvt implant year tvt implant patient subject cure p trend patient object cure p trend signific trend de novo oab symptom report year follow serious earli late complic urethralbladd injuri persist groin thigh pain sexual dysfunct requir mesh remov detect univari analysi reveal risk factor ie age bodi mass index bmi menopaus obstetr factor preoper iciq sf questionnair statist associ failur tvt procedur conclus conclus year follow result studi demonstr tvt safe effect option treatment sui low rate post oper groin thigh pain
|
D014550;D053825;D014549
|
T047;T074;T046
|
36,295,572
|
hla b heavi chain homo oligom promot cytotox nk cell via activ pikakt signal background object ankylos spondyl chronic inflammatori diseas high link express human leukocyt antigen b hla b genotyp hla b heavi chain b hc innat characterist slowli fold result accumul misfold b hc format homo oligomer b hc molecul homo oligomer b hc act ligand kirdl interact homo oligomer b hc molecul kirdl trigger surviv activ kirdl posit nk cell howev effect homo oligomer b hc molecul associ kirdl cytotox activ nk cell cytokin express remain unknown materi method hla b hc overexpress hmycr cr cell line western blot quantit rt pcr use analyz protein express cytokin express respect cr b cell overexpress b hc co cultur nk mi cell flow cytometri use analyz cytotox mediat nk mi cell result result reveal nk mi cell regul express perforin enhanc cytotox activ via augment pikakt signal co cultur cr b cell suppress dimer b hc format treatment inhibitor pik ly anti b hc monoclon antibodi reduc perforin express nk mi co cultur cr b co cultur cr b cell suppress tnf il express nk mi cell conclus stimul nk cell mediat cytotox homo oligomer b hc molecul may contribut pathogenesi
|
D019869;D013167
|
T047;T126;T116
|
36,295,571
|
addit prognost valu tissu doppler evalu patient aortic stenosi left ventricular systol dysfunct undergo aortic valv replac background object patient surgic aortic stenosi show impair diastol fill risk factor earli late mortal aortic valv replac avr pauciti inform concern impact restrict diastol fill evolut diastol dysfunct earli medium term post avr aim determin prognost valu presenc restrict left ventricular lv diastol fill pattern lvdfp dilat left atrium la patient lv systol dysfunct lvef lt underw avr defin independ predictor immedi long term prognosi valu preoper risk estim materi method studi prospect includ patient surgic lvef lt underw avr preoper echocardiograph examin repeat day month year surgeri evalu lvef diastol function la dimens index mmm depend lv systol perform patient classifi group lvef group b lvef lt result main echograph independ paramet earli late postop death restrict lvdfp signific pulmonari hypertens lv end systol diamet lvesd gt mm presenc second degre mitral regurgit restrict lvdfp la dimens gt mmm independ predictor fatal outcom p conclus assess diastol function la dimens reliabl paramet predict fatal outcom hospit heart failur independ increment prognost valu patient surgic complet evalu lvdfp echograph measur includ tdi routin part preoper assess patient lv systol dysfunct undergo avr
|
D019918;D001024;D018487
|
T061;T047;T046
|
36,295,570
|
monkeypox patient control hiv infect initi present fever pain pharyng tonsil background object case emerg outsid central west african countri diseas endem world health organ recent declar human monkeypox public health emerg intern concern typic symptom diseas includ fever myalgia lymphadenopathi follow rash symptom may occur immunocompromis patient includ patient uncontrol human immunodefici virus hiv infect may risk sever cours case present present case year old male patient brazilian descent monkeypox initi symptom fever general discomfort pain pharyng tonsil final papular rash anogenit area diseas progress presum date infect sexual contact unknown male eight day first symptom occur patient known control hiv infect main reason initi present hospit pain pharyng tonsil limit food intak monkeypox infect confirm via pcr test swab sampl cutan lesion adequ system local analgesia enabl oral food uptak antivir therapi tecovirimat administ due stabl immun status patient mild clinic symptom cover possibl bacteri superinfect syphili infect tonsil antibiot therapi ceftriaxon ad sever day present inflamm pharynx resolv follow non pain mucos peel patient follow telephon call report complet recoveri skin lesion complet dri day first symptom conclus pain pharyng tonsil rare earli symptom monkeypox high relev everyday clinic practic particular patient risk factor monkeypox infect clinic microbiolog test monkeypox perform clinic present pharyng tonsil
|
D015658;D045908;D014069;D010612;D005076
|
T184;T047
|
36,295,569
|
local pattern rabc associ murin human sperm format background object septin sept high conserv gtp bind protein fourth compon cytoskeleton polymer sept contribut sever critic cellular process cytokinesi cytoskelet remodel vesicl transport previous studi found sept mutat result teratozoospermia gt sperm morpholog defect sept interactor also identifi proteom assay one peptid map rabb rabc studi rab famili focus raba regul exocytosi neurotransmitt acrosom reaction howev general express pattern rab famili member human spermatogenesi associ rab teratozoospermia owe sept mutat larg unknown materi method human sperm murin male germ cell collect studi immunofluoresc analysi appli collect sperm result studi observ rabc transcript abund raba b human testicular tissu human spermatogenesi rabc protein main enrich elong spermatid rabb undetect matur human spermatozoa rabc concentr postacrosom region neck midpiec rabc signal deloc within human spermatozoa harbor sept mutat decreas signal accompani defect head tail compar healthi control determin whether rabc involv morpholog format head tail sperm separ murin testicular tissu isol elong spermatid studi found rabc particular express manchett structur assist sperm head shape spermatid head also local sperm tail conclus base result suggest local rabc protein murin human sperm associ sept mutat induc morpholog defect sperm
|
D000072660
|
T033;T047
|
36,295,568
|
sudden occurr pacemak captur failur irrevers electropor ablat prostat cancer post covid patient case report irrevers electropor ire ablat novel treatment option local prostat cancer present case abrupt fatal arrhythmia ire procedur prostat cancer patient implant perman pacemak year old male patient pacemak due sick sinus syndrom syncop schedul ire prostat ablat surgeri general anesthesia histori recov coronavirus diseas covid vaccin recov without sequala pacemak interrog reprogram asynchron aoo mode carri surgeri howev sinus paus occur repeat ablat puls deliveri first sinus paus decreas continu arteri blood pressur abp deliveri second third puls ident sinus paus observ due failur captur howev atrial pace rhythm recov instant vital sign becam accept although sinus paus recov gradual durat thereof increas deliveri ire puls subsequ abrupt decreas seen blood pressur pacemak urgent reprogram doo mode pace failur hemodynam advers event patient pacemak close cardiac monitor addit interrog pacemak electromagnet interfer emi procedur recommend especi case diseas may aggrav cardiac vulner covid
|
D000086382;D011471;D010138
|
T047;T191;T074;T067
|
36,295,567
|
manag infecti diseas comorbid tuberculosi tuberculosi tb infect instig bacillus mycobacterium tuberculosi mtb
|
D014376;D009169;D003141
|
T047;T007
|
36,295,566
|
ten improv cisplatin induc neuropathi lung cancer patient background cisplatin induc peripher neuropathi common complic cisplatin therapi develop patient lung cancer effect prevent measur occur effect therapi except symptomat studi aim assess effect transcutan electr nerv stimul ten therapi pain intens qualiti life patient cisplatin induc neuropathi materi method prospect cohort studi perform clinic center serbia initi evalu newli diagnos patient lung cancer patient peripher neuropathi patient continu studi start cisplatin chemotherapi forti patient develop cisplatin induc neuropathi manifest neuropath symptom proven eng examin patient cisplatin induc neuropathi treat ten therapi neuropath pain qualiti life evalu use follow questionnair diagnosi cisplatin therapi four week ten use dn vas scale eortc qlq c fact l result two third patient cisplatin induc neuropathi male major smoker adenocarcinoma common follow squamous small cell carcinoma applic ten therapi posit effect reduc neuropath pain increas qualiti life patient pain cisplatin induc neuropathi vas dn score signific decreas ten therapi comparison valu cisplatin therapi p lt ten therapi patient signific higher valu domain eortc qlq c fact l comparison valu cisplatin therapi p lt conclus applic ten therapi posit effect reduc neuropath pain increas qualiti life patient lung cancer cisplatin induc neuropathi
|
D004561;D008175;D009437
|
T061;T184;T047;T191
|
36,295,565
|
rare case left ventricular malign peripher nerv sheath tumour case report review literatur malign peripher nerv sheath tumour mpnst aggress uncommon cancer develop peripher nerv sheath primari cardiac mpnst extrem rare find specif imag clinic characterist hand case report literatur thus littl still known cardiac comput tomographi ct cardiac magnet reson imag cmri import mean assess cardiac morpholog function prefer cours treatment patholog full surgic resect tumour negat clear margin follow adjuv radiotherapi chemotherapi present case year old woman signific cardiovascular symptom incident diagnos routin transthorac echocardiographi tte cardiac mass locat left ventricl
|
D018319;D018317
|
T191
|
36,295,564
|
young children bucket handl tear discoid later meniscus success treat use arthroscop saucer repair two case report observ symptomat discoid later meniscus young children infrequ object report demonstr use arthroscop saucer repair treat bucket handl tear later discoid meniscus two young children two young children month old girl year old boy present bucket handl tear complet type later discoid meniscus patient receiv arthroscop saucer repair full knee extens long leg cast appli one month surgeri two patient abl achiev full rang motion oper knee without limp present antalg gait third month surgeri patient parent felt satisfi treatment year follow up respect result demonstr arthroscop saucer repair seem effect treatment bucket handl tear later discoid meniscus young children even younger year old report youngest case month old girl comparison find literatur review
|
D000070600;D002357
|
T047;T037
|
36,295,563
|
cpap therapi depress anxieti symptom patient moder sever obstruct sleep apnea syndrom background object link sleep apnea syndrom osa depress anxieti symptom under mechan fulli understood studi aim determin preval symptom patient osa evalu impact continu posit airway pressur cpap depress anxieti score materi method nineti nine consecut new patient diagnos moder sever apnea hypopnea index ahi eventsh osa accept cpap therapi patient complet patient health questionnair phq depress symptom general anxieti questionnair gad anxieti symptom cpap treatment month year cpap therapi complianc score phq gad cut point use indic presenc clinic depress anxieti symptom result forti eight individu phq score cut point twenti seven particip gad score cut point signific correl shown phq score bmi p lt ahi p lt odi p lt ess p lt gad score p lt p lt gad correl ahi p lt odi p lt p lt phq gad score decreas signific month cpap therapi group year cpap use conclus osa patient screen depress anxieti furthermor cpap first choic treatment start treatment depress anxieti symptom
|
D045422;D020181
|
T061;T047
|
36,295,562
|
bodi weight may role neuropathi mobil moder sever covid exploratori studi background object among extra pulmonari manifest covid neuromuscular sign symptom frequent aim assess correl neuromuscular abnorm electrophysiolog mobil measur berg balanc scale time go test twice least week hospit discharg month later take account cognit perform nutrit muscl strength submaxim exercis capac materi method patient year old accept particip studi dyspnea score borg scale histori neurologyneuromuscularorthoped disord high frequenc overweightobes weight loss hospit stay two evalu includ physic examin cognit assess nutrit evalu muscl strength hand grip quadricep dynamometri electromyographi barthel index six minut walk test mwt berg balanc scale time go test bivari repeat measur covari analys perform signific level result electrophysiolog abnorm evid patient associ diminish perform mwt berg balanc scale time go test evalu evalu score berg balanc scale relat bodi mass index bmi hospit admiss mwt mancova r p time perform time go test relat electrophysiolog abnorm weight loss hospit stay sex handgrip strength mwt mancova r p lt conclud hospit discharg patient moder sever covid may neuromuscular abnorm relat bmiweight loss contribut mobil decreas patient moder sever covid high bmi larg weight loss neuromuscular intend mobil assess could requir provid earli rehabilit apart mwt handgrip dynamometri time go test use tool quick assess fit mobil
|
D004856;D000086382
|
T047;T040;T067
|
36,295,561
|
awar knowledg percept attitud toward famili inherit cancer background object world health organ report million death cancer mortal rate earli detect cancer decreas mortal increas chanc cure saudi arabia multipl studi perform awar attitud toward cancer studi evalu awar famili inherit cancer materi method cross section observ survey awar knowledg attitud saudi women toward famili inherit cancer estim sampl size questionnair distribut social media platform januari januari result particip major bachelor degre half know famili histori relat cancer approxim awar genet test common indic genet test premarit test invers relationship note awar famili inherit cancer age p ci howev awar inherit famili cancer posit associ awar associ genet mutat cancer p ci knowledg genet test p gt ci conclus result reveal saudi women especi older adult suboptim knowledg inherit famili cancer poor attitud toward genet screen recommend increas public awar regard risk factor screen inherit famili cancer
|
D007722;D009369
|
T053;T191
|
36,295,560
|
near infrar spectroscopi use valid hyperventil test background hyperventil test use clinic practic diagnosi therapeut purpos howev absenc standard protocol procedur vari signific predispos test subject risk cerebr hypoxia ischemia near infrar spectroscopi nir noninvas techniqu perform cerebr oximetri monitor use present studi identifi minimum decreas end tidal co etco hyperventil necessari induc chang nir materi method recruit volunt preexist medic condit subject ask breath baselin rate breathsmin min hyperventil doubl respiratori rate next min paramet record procedur region cerebr oxyhemoglobin deoxyhemoglobin concentr via nir etco respiratori rate result hyperventil etco valu drop vs baselin subject chang cerebr oximetri observ subject n regist decreas etco subject n decreas etco accord auc roc analysi cutoff valu etco decreas gt found predict chang oximetri auc roc p lt seven subject report symptom dizzi vertigo numb throughout procedur conclus rise respiratori rate alon effect predict occurr cerebr vasoconstrictor respons induc hyperventil synchron etco cerebr oximetri monitor could use valid clinic test nir seem use tool predict vasoconstrict follow hyperventil
|
D006985;D019265
|
T033;T059
|
36,295,559
|
pd l gene polymorph rs g gt c rs gt promis prognost marker tripl negat breast cancer patient background object tripl negat breast cancer tnbc high heterogen subtyp associ unrespons therapi henc high mortal rate studi aim investig prognost role rs g gt c rs gt polymorph pd l program death ligand tnbc patient materi method formalin fix paraffin embed tissu tnbc patient blood sampl healthi donor genotyp subsequ extens statist analysi perform order investig clinic valu polymorph tnbc result regard rs g gt c found cg genotyp common among women harbor stage iv breast tumor p recur p die p similar rs gt genotyp aa associ wors prognosi sinc common genotyp among stage iv tumor p tnbc patient relaps p die p statist analysi reveal rs g gt c genotyp cg rs gt allel aa strong associ inferior dfs os interv moreov reveal women harbor mutat genotyp snps shorter diseas free kaplan meier p cox analysi p overal kaplan meier p cox analysi p surviv compar patient normal genotyp least one snp multivari analysi also show presenc mutat genotyp snps strong independ marker predict shorter dfs p os p conclus studi reveal pd l rs g gt c rs gt polymorph differenti express cohort tnbc patient distribut associ marker unfavor prognosi wors surviv
|
D060890;D064726
|
T129;T191;T116
|
36,295,558
|
granulocyt apheresi associ anti pd therapi melanoma field advanc melanoma urgent need investig novel approach target specif compon cancer immun cycl beyond immun checkpoint inhibitor author review basic understand role neutrophil cancer biolog latest clinic evid support correl cancer associ neutrophil prognosi respons immunotherapi advanc melanoma final propos granulocyt monocyt apheresi emerg non pharmacolog treatment current dermatolog could becom investig treatment target melanoma associ neutrophil could potenti use combin usual immun checkpoint inhibitor
|
D008545;D001781
|
T061;T191
|
36,295,557
|
lower platelet lymphocyt ratio associ poor prognosi newborn patient nicu background platelet lymphocyt ratio plr report relat outcom intens care unit icu patient howev littl known associ prognosi newborn patient neonat icu nicu aim present studi investig prognost signific plr newborn patient nicu method data newborn patient nicu extract multiparamet intellig monitor intens care iii mimic iii databas initi plr valu blood examin within h analyz spearman correl use analyz associ plr length hospit icu stay chi squar test use analyz associ plr mortal rate multivari logist regress use determin whether plr independ prognost factor mortal area receiv oper characterist roc curv use assess predict abil model combin plr variabl result total patient enrol plr negat associ length hospit stay icu stay hospit stay p lt icu stay p lt plr signific correl hospit mortal p lt lower plr associ higher hospit mortal ci p day mortal ci p prognost predict abil model combin plr variabl hospit mortal good auc model ci p lt auc model ci p lt conclus plr novel independ risk factor newborn patient nicu
|
D007363;D008214
|
T025;T073;T093
|
36,295,556
|
narrat review histori burn relat depress stress reaction root burn care date back sever millennia recognit treatment psychiatr trauma contemporari journey understand burn care evolv larg separ understand psychiatri howev proper care burn patient reli comprehens disciplin histor high burn mortal rate caus clinician focus physiolog caus burn mortal burn care improv th centuri provid began focus long term health outcom burn patient includ mitig mental health consequ trauma shift coincid advanc understand psycholog sequela trauma subsequ associ burn trauma mental ill began emerg current standard care result thousand year evolv practic theori yet understand pathophysiolog depress among survivor sever burn injuri far complet take measur past aim provid context evid current standard emphas area futur line research
|
D013313;D002056
|
T037;T048
|
36,295,555
|
cluster comorbid short term prognosi acut heart failur among elder patient retrospect cohort studi background object elder patient affect acut heart failur ahf often show differ pattern comorbid paper aim evalu chronic comorbid cluster pattern comorbid strong relat hospit death ahf materi method patient admit ahf intern medicin depart retrospect evalu main outcom studi hospit death admiss ahf age sex charlson comorbid index cci differ chronic patholog investig associ comorbid studi pearson bivari test consid level p signific consid p lt strong signific thus identifi cluster comorbid associ main outcom test cci cluster hospit death logist regress analysi assess accuraci predict roc curv analysi result total consecut patient age year male total subject reach main outcom cci cluster comorbid emerg associ hospit death ahf cci six cluster show accur predict hospit death conclus cci specif cluster comorbid associ hospit death ahf among elder patient specif phenotyp show greater associ wors short term prognosi generic scale cci
|
D006333
|
T047;T046
|
36,295,554
|
transit chang fatigu relat symptom due long covid singl center retrospect observ studi japan background object chang post covid condit pcc characterist caus viral variant yet clarifi aim character differ clinic background manifest long covid patient infect delta variant infect omicron variant materi method studi singl center retrospect observ studi patient visit covid aftercar outpati clinic cac establish okayama univers hospit japan period februari juli classifi onset covid patient three group preced delta domin omicron domin period base preval period variant prefectur result total patient exclud patient patient classifi preced delta domin omicron domin period respect patient infect omicron domin period signific fewer hospit milder ill vaccin earlier visit cac patient infect delta domin period patient infect omicron domin period signific lower frequenc dysosmia vs p lt dysgeusia vs p lt hair loss vs p lt higher frequenc fatigu vs p lt insomnia vs p lt cough vs p lt patient infect delta domin period conclus transit chang long covid symptom caus two variant character
|
D000086382
|
T047;T067
|
36,295,553
|
risk factor delay diagnosi acut cholecyst among rural older patient retrospect cohort studi background object acut cholecyst caus acut abdomin pain may necessit emerg surgeri intens antibiot therapi percutan drainag depend patient condit symptom acut cholecyst older patient may atyp difficult diagnos caus delay treatment clarifi risk factor delay diagnosi among older patient could lead earli diagnosi treatment acut cholecyst studi aim explor risk factor delay diagnosi acut cholecyst among rural older patient materi method retrospect cohort studi includ patient age year diagnos acut cholecyst rural communiti hospit primari outcom time symptom onset acut cholecyst diagnosi review electron medic record patient acut cholecyst investig whether diagnos treat condit time symptom onset result averag age control exposur group year standard deviat sd year sd respect addit particip control exposur group respect men logist regress model reveal serum albumin level signific relat time diagnosi gt day odd ratio confid interv conclus low serum albumin level relat delay diagnosi cholecyst male sex presenc abdomin pain high bodi mass index bmi may relat earli cholecyst diagnosi clinician concern delay cholecyst diagnosi older femal patient poor nutrit condit includ low serum albumin level low bmi vagu symptom abdomin pain
|
D041881;D002764
|
T047
|
36,295,552
|
advantag use high sensit troponin compar convent troponin shorten time rule outin acut coronari syndrom chest pain patient present emerg depart background object aim compar time diagnosi acut coronari syndrom use high sensit troponin hstni convent troponin tni patient present emerg depart ed chest pain materi method observ prospect studi involv patient present ed santandrea hospit univers la sapienza rome itali chest pain januari decemb serum troponin drawn present andor h clinic indic depend date recruit patient either hstni abbott laboratori tni abbott laboratori perform primari endpoint time diagnosi index visit result total patient recruit male median age year interquartil rang year patient evalu hstni tni total patient diagnosi acut coronari syndrom ed median time diagnosi evalu tni min iqr min use hstni led signific shorter time diagnosi median min iqr min p lt conclus studi confirm patient present emerg depart chest pain use hstni associ reduc time rule inout ac consequ hstni routin use tni rapid identif ac benefit patient relat cost
|
D019210;D054058
|
T123;T047;T116
|
36,295,551
|
cardiovascular complic obstruct sleep apnea intens care unit beyond obstruct sleep apnea osa common diseas high degre associ possibl etiolog factor sever cardiovascular diseas patient admit intens care unit icu incred sick multipl co morbid substanti risk mortal studi cardiovascular manifest diseas process patient osa admit icu intrigu impact like signific although much known cardiovascular complic associ osa still pauciti high qualiti evid tri establish causal two studi explor potenti impact therapeut intervent posit airway pressur therapi pap cardiovascular complic icu patient also need encourag studi review literatur current avail topic potenti futur research direct clinic signific relationship osa cardiovascular diseas process icu beyond
|
D020181;D002318
|
T047
|
36,295,550
|
associ admiss procalcitonin level sever covid pneumonia retrospect cohort studi background object elev procalcitonin level classic link bacteri infect data associ elev procalcitonin outcom coronavirus diseas covid conflict link associ bacteri co infect other correl elev diseas sever without coexist bacteri infect aim investig associ high procalcitonin sever covid materi method hospit patient confirm covid pneumonia divid two group normal procalcitonin group high procalcitonin group gt ngml patient concomit bacteri infect admiss exclud primari outcom need intens care unit icu admiss progress invas mechan ventil imv hospit day mortal result includ patient normal procalcitonin group patient high procalcitonin group mean age year femal higher number patient elev procalcitonin group requir icu admiss vs p lt imv vs p lt hospit mortal signific higher elev procalcitonin group vs p lt adjust covari procalcitonin gt ngml independ predictor progress imv ci p icu admiss ci p hospit mortal ci p elev procalcitonin level strongest predictor hospit mortal conclus measur procalcitonin prognost role among covid patient admiss procalcitonin level identifi patient risk icu admiss progress imv hospit mortal
|
D000086382;D011014
|
T047;T050;T067
|
36,295,549
|
comparison surgic outcom singl use reusabl flexibl ureteroscop renal stone manag systemat review meta analysi background object dispos flexibl ureteroscop wide use cost effect higher steril potenti compar reusabl flexibl ureteroscop studi aim compar surgic outcom complic rate patient undergo reusabl dispos flexibl ureteroscop stone surgeri fur urinari stone diseas materi method systemat review meta analysi conduct prefer report item systemat review meta analys prisma guidelin systemat review regist prospero crd clinic trial compar reusabl dispos fur stone diseas found pubm embas cochran librari web scienc march particip patient upper urinari tract stone intervent reusabl dispos fur outcom includ stone free rate oper time length hospit stay complic rate compar analysi result overal studi identifi remov duplic studi studi remain thirti two studi exclud screen studi met elig criteria differ stone free rate sfr dispos reusabl fur p ci oper time differ identifi reusabl dispos fur group p md ci hospit stay also differ two group p md ci signific differ complic rate two group p ci conclus differ sfr oper time length hospit stay complic rate reusabl dispos fur dispos fur may compar altern reusabl fur
|
D007669;D014545
|
T047;T031
|
36,295,548
|
comparison oncolog function outcom brachytherapi radic prostatectomi local prostat cancer background object compar oncolog function outcom brachytherapi bt radic prostatectomi rp patient local prostat cancer pca materi method retrospect analyz data patient local pca treat bt n rp n northern jiangsu peopl hospit januari decemb biochem relaps free surviv brfs cancer specif surviv css compar treatment modal multivari cox regress analysi use evalu brfs health relat qualiti life hrqol measur use expand prostat cancer index composit epic questionnair result bt group older higher initi psa ipsa year brfs bt group versus rp group p year css bt group versus rp group p base multivari cox regress analysi gleason score main independ prognost factor brfs regard hrqol compar baselin treatment produc signific decreas differ aspect hrqol month treatment patient bt group lower hrqol regard urinari irritationobstruct bowel function bother patient rp group lower hrqol concern urinari incontin sexual function bother signific differ hrqol aspect two group follow year compar baselin conclus bt provid equival oncolog control outcom term brfs css patient local pca compar rp gleason score main independ prognost factor brfs bt better hrqol compar rp except urinari irritationobstruct bowel function bother return baselin year
|
D001918;D011471
|
T061;T191
|
36,295,547
|
hybrid manag aortobronchi fistula patch aortoplasti aortic coarctat patient sar cov pneumonia case report review literatur aortobronchi fistula rare caus repeat hemoptysi potenti fatal condit left untreat present case year old man repeat hemoptysi excess cough epistaxi ongo sever day sar cov pneumonia diagnosi patient histori patch aortoplasti aortic coarctat aortic valv replac mechan valv aortic insuffici due bicuspid aortic valv age comput tomographi scan perform present reveal sever dilat ascend aorta thorac aorta pseudoaneurysm site former coarctat aortobronchi fistula suggest thicken left lower lobe apic segment bronchus contact pseudoaneurysm sign alveolar hemorrhag respect segment patient treat thorac endovascular aneurysm repair tevar prior hemi aortic arch debranch transposit left common carotid arteri subclavian arteri close chest surgic approach case report togeth systemat review literatur highlight import consid aortobronchi fistula differenti diagnosi hemoptysi patient prior histori thorac aorta surgic intervent regardless associ patholog take account endovascular hybrid techniqu altern open surgic repair carri high risk morbid mortal
|
D001017;D017541;D001983;D017544;D057510;D019917;D000086382
|
T061;T190;T067;T019;T047;T046
|
36,295,546
|
genet genom advanc rewrit pediatr cancer research clinic care last two decad thank data obtain human genom project develop next generat sequenc ngs technolog research oncolog produc extrem import result understand genom landscap pediatr cancer main caus death childhood ngs provid signific advanc medicin detect germlin somat driver variant determin develop progress mani type cancer allow distinct hereditari non hereditari cancer character resist mechan also relat alter epigenet apparatus quantifi mutat burden tumor cell combin approach next generat technolog allow us investig numer molecular featur cancer cell effect environ discov follow path person therapi defeat ancient diseas victori defeat paper provid overview result obtain last decad genom studi carri pediatr cancer contribut accur faster diagnosi stratif patient develop new precis therapi
|
D057285;D009369
|
T061;T191;T091
|
36,295,545
|
gastrointestin involv extra digest diseas role fecal calprotectin fecal calprotectin fc sensit marker inflamm gastrointestin tract clinic util appreci intestin extraintestin diseas recent evid suggest link intestin inflamm dermatolog rheumat neurolog diseas review focus role fc non gastrointestin diseas rheumat dermatolog neurolog last least sar cov infect
|
D000086382;D005767
|
T047;T067
|
36,295,544
|
evalu sagitt spinopelv align analges efficaci lumbar epidur steroid inject geriatr patient background object aim studi evalu impact sagitt imbal base pelvic incid lumbar lordosi pi mismatch analges efficaci epidur steroid inject geriatr patient materi method patient age year older receiv lumbar epidur steroid inject fluoroscopi enrol cutoff pi mismatch gt use indic mark sagitt imbal cross section area psoa paraspin muscl well paraspin fat infiltr grade measur decreas pain score four week inject consid good analgesia variabl compar pi gt group multivari analysi use identifi factor relat pain relief inject result total patient consist patient pi gt group respect final analyz femal patient patient lumbar surgeri histori smaller cross section area psoa muscl predomin observ patient sagitt imbal differ analges outcom inject accord pi mismatch good analgesia vs p multivari analysi show pre inject opioid use moder sever foramin stenosi high grade paraspin fat infiltr signific associ poor analgesia inject conclus signific correl sagitt spinopelv align pain relief lumbar epidur steroid inject geriatr patient
|
D008159;D008141
|
T023;T047
|
36,295,543
|
chang pattern antihyperglycaem treatment among patient type diabet hungari nationwid data regist base analysi background object last coupl year pharmacolog manag patient type diabet mellitus tdm mark renew aim studi analys chang prescrib pattern antidiabet drug treat patient tdm hungari materi method retrospect nationwid analysi use central databas nation health insur fund present annual number proport tdm patient differ treatment regimen result period number incid case decreas preval case increas patient metformin met monotherapi highest preval preval insulin in monotherapi continu slight decreas sulfonylurea su monotherapi mark decreas dipeptidyl peptidas dpp inhibitor remain popular monotherapi dual combin met tripl combin met su preval patient sodium glucos co transport sglt inhibitor increas monotherapi lt dual combin met lt tripl oral combin met su dpp inhibitor preval patient use glucagon like peptid receptor agonist glp ras also increas remain around monotherapi combin initi antihyperglycaem treatment met monotherapi frequent use regim follow monotherapi sus in initi met monotherapi incid rate patient add glp ras add sglt inhibitor slowli increas subsequ month respect conclus period document import chang trend antihyperglycaem therapeut pattern patient tdm follow new scientif recommend remain expect regard time magnitud effort warrant implement new agent cardiovascularren benefit therapeut manag time much larger proport tdm popul without delay
|
D003924;D000077203;D054873;D008687;D027981
|
T121;T123;T116;T109;T047
|
36,295,542
|
ascit first atyp clinic manifest de novo follicular lymphoma follicular lymphoma common indol non hodgkin lymphoma usual initi detect lymph node primari extranod nhl common primarili local gastrointestin tract present one unusu case ileum fl ascit first clinic sign year old femal patient present emerg depart evalu mild abdomin pain abdomin swell go three day follow bloat occasion pain spine abdomin contrast enhanc ct reveal contrast stagnat distal part ileum ileum wall cm length thicken cm tumor mass infiltr layer ileum mesenter lymphadenopathi cm diamet signific ascit upper ileum wall veget mass describ cm diamet patient emerg laparotomi ileocol resect latero later ileocol anastomosi microscopi find termin ileum region lymph node show domin cleav cell irregular nuclei correspond centrocyt larg non cleav cell correspond centroblast microscopi high power field final diagnosi follicular lymphoma clinic stage e histolog grade berard mann criteria
|
D008224;D008228
|
T191
|
36,295,541
|
investig influenc anaesthesiolog cancer resect surgeri oncolog outcom role experiment vivo model incid societ burden cancer increas global surgeri indic major solid tumour recent research emerg field onco anaesthesiolog suggest anaesthet analges intervent periop period could potenti influenc long term oncolog outcom prospect randomis control clinic trial research method conclus prove causal relationship anaesthet techniqu cancer recurr live anim vivo experiment model may realist test biolog plausibl hypothes mechan underpin limit vitro model review outlin advantag limit avail anim model cancer might use periop cancer metastasi model includ spontan induc tumour allograft xenograft transgen tumour model
|
D000776;D000777;D009369
|
T121;T039;T191;T091
|
36,295,540
|
predict prognosi patient trauma use machin learn background object develop machin learn algorithm analyz trauma relat data predict mortal chronic care need patient trauma materi method recruit admit patient trauma collect clinic data subject databas differ machin learn techniqu chose one highest accuraci use cross valid primari endpoint mortal secondari endpoint requir chronic care result data patient collect use extrem gradient boost xgbt machin learn model creat two algorithm complet model short term model complet model exhibit recal recoveri chronic care mortal complic short term model fit ed display recal recoveri chronic care mortal conclus develop machin learn algorithm display good recal healthi recoveri group unsatisfactori result requir chronic care risk mortal predict power algorithm may improv implement featur age group classif sever select score calibr trauma relat variabl
|
D000069550;D000465
|
T170;T066
|
36,295,539
|
chang trend lower gastrointestin endoscopi conduct children adolesc covid outbreak korea background object coronavirus diseas covid pandem affect medic practic divers way aim investig chang trend lower gastrointestin lgi endoscopi conduct children adolesc covid outbreak korea materi method multicent retrospect studi conduct korea includ children adolesc age lt year undergon first lgi endoscopi compar clinicodemograph endoscop factor group divid accord pre postcovid era korea result includ patient studi colonoscopi instead sigmoidoscopi conduct patient postcovid era compar precovid era vs p diagnosi inflammatori bowel diseas ibd also signific higher postcovid era compar precovid era vs p lt accord multivari logist regress analysi age lgi endoscopi lgi bleed indic ibd diagnosi independ associ use colonoscopi sigmoidoscopi odd ratio confid interv ci p lt ci p ci p respect conclus covid pandem chang lgi endoscopi practic trend pediatr gastroenterologist korea tend perform lesser lgi endoscopi compar previous year conduct signific colonoscopi sigmoidoscopi postcovid era furthermor colonoscopi signific associ diagnosi ibd well signific increas ibd diagnosi postcovid era
|
D000086382;D015212
|
T047;T067
|
36,295,538
|
molecular pathway relat sulforaphan adjuv treatment nanomedicin perspect breast cancer cancer multifactori diseas difficult identifi specif agent respons diseas progress develop lifestyl diet shown play signific role divers natur compound demonstr efficaci develop novel cancer therapi includ sulforaphan isothiocyan methylsulfinyl butan compound found broccoli crucifer veget promot key biolog process apoptosi cell cycl arrest autophagi suppress key signal pathway pikaktmtor pathway breast cancer cell howev one primari challeng sulforaphan treatment low solubl water oral bioavail consequ sever investig conduct use compon complex nanoparticl result superior outcom combin chemotherapi drug studi discuss properti benefit sulforaphan cancer therapi well abil form complex nanomolecul chemotherapeut agent synerg antitumour respons breast cancer cell
|
D001943;D016588
|
T121;T039;T191
|
36,295,537
|
effect individu inform emot support educ midwiferi student anxieti covid pandem background object midwiferi student abl particip internship program relat practic covid pandem kept meet graduat requir could one one observ clinic case manag studi aim determin effect individu inform emot support educ ies midwiferi student anxieti level covid pandem materi method experiment studi two stage first stage research determin anxieti level student second stage student high level anxieti provid ies ies conduct interview onlin platform took minimum min student anxieti level measur one week ies result statist signific differ found student state anxieti scale score ies p ies student high anxieti level covid relat diseas death possibl lose love one educ rate fell differ signific p conclus ies posit affect student anxieti level even show interest make peopl feel care valu peopl sensit need studi student high anxieti level sent consult expert follow research
|
D000086382;D008880
|
T047;T091;T097;T067
|
36,295,536
|
effect covid endocrin patient cross section studi introduct home confin due covid lockdown led chang daili routin includ social interact well restrict possibl play sport eat habit chang could greater impact patient suffer chronic diseas endocrin patient especi emot behavior dimens materi method studi aim assess effect covid induc quarantin daili habit group patient endocrin disord focus food consumpt eat habit sleep confin eighti five endocrin patient enrol structur interview administ investig socio demograph inform general medic condit habit adopt quarantin patient underw spielberg state anxieti inventori stai assess state anxieti result result show subject main sedentari lifestyl found signific increas number cigarett smoker meal consum confin well high rate sleep disturb especi insomnia notabl physic well result predict factor ci wherea anxieti risk factor sleep disord ci work public privat offic student conclus chang daili habit like due alter routin result greater boredom inact day addit futur research focus import patient adher therapi
|
D000086382;D012893
|
T047;T067;T048
|
36,295,535
|
biomark alzheim diseas dementia next pathophysiolog support clinic practic drug develop neurodegen diseas heterogen group disord character gradual progress neuron loss central nervous system
|
D000544
|
T047;T048
|
36,295,534
|
fatal form covid young male bodybuild anabol steroid use first autopsi case report case year old male patient bodybuild trainer user anabol androgen steroid aass year found cardio respiratori arrest home perform medico legal autopsi sever form covid aortic atherosclerot plaqu old myocardi infarct found sar cov rt pcr test necropt lung fragment posit b genet line histopatholog examin show microthrombi endothel cerebr tissu massiv pulmonari edema diffus alveolar damag grade pulmonari thromboembol hepat peliosi sever nesidioblastosi immunohistochem examin show sar cov posit myocardium lung kidney pancrea ace receptor posit organ also spleen liver hla allel b b c c drb drb dqb dqb also identifi conclus death due genet predisposit long term abus aass favor develop pluriorgan patholog tissu terrain recent consumpt aass influenc immun system time infect
|
D000086382
|
T047;T067
|
36,295,533
|
remimazolam general anesthesia patient sever aortic stenosi undergo high risk surgeri case report high risk surgeri patient sever aortic stenosi challeng anesthesiologist result hemodynam deterior even mortal describ case remimazolam use induc maintain general anesthesia high risk noncardiac surgeri accompani ongo bleed year old man sever schedul undergo proxim gastrectomi due ongo gastrointestin bleed sever anemia remimazolam novel ultra short act benzodiazepin administ along remifentanil induct mainten general anesthesia throughout anesthet process patient cardiac index system vascular resist well preserv without vasopressor support remimazolam seem possibl effect relat safe agent induct mainten general anesthesia patient sever undergo high risk noncardiac surgeri bleed
|
D001024
|
T047
|
36,295,532
|
prepar pregnanc women system lupus erythematosus multidisciplinari approach pregnanc one challeng process human bodi expos healthi mother carri term genet differ new born immun system adapt toler new status avoid reject autoimmun disord motherhood even challeng addit medic counsel mother care foetus develop check necessari aspect supplementari mother care pregnanc progress track associ well establish medic procedur protocol counsel pre post concept still underestim scarc appli inde past decad medic counsel particular popul chang signific healthcar provid point view requir ensur smooth control pregnanc evolut one frequent autoimmun diseas affect young femal fertil year system lupus erythematosus sle like heterogen diseas expos mother sever organ threaten complic unpredict evolut diseas treatment signific affect mother willing engag potenti riski pregnanc well likeli carri term without impair good collabor patient rheumatologist obstetrician therefor mandatori order allow mother make inform decis pursu pregnanc b ensur perfect synchron pregnanc term treatment c avoid minim potenti complic best approach achiev outcom pregnanc plan moreov know one desir prerequisit success pregnanc evolut sle mother stabl inact quiescent diseas least six month prior concept plan becom recommend procedur one particular aspect requir attent concept treatment scheme appli deliveri autoantibodi influenc signific cours pregnanc view futur sle mother ideal benefit preconcept counsel within agre care pathway multidisciplinari team includ least rheumatologist obstetrician employ throughout pregnanc decid appropri time concept compat medic respect diseas activ well monitor organ involv foetus develop progress
|
D011248;D008180
|
T047;T046
|
36,295,531
|
multipl post sar cov infecti complic kidney transplant recipi forti seven year old recipi late period kidney transplant chronic estim glomerular filtrat rate egfr mlmin fulli vaccin covid diagnos sar cov infect novemb initi mild cours diseas develop multiorgan failur requir period respiratori dialysi therapi covid diseas complic multipl infect clostridioid difficil infect streptococcus epidermidi bacteriemia klebsiella pneumonia candida glabrata urinari tract diseas cytomegalovirus infect oral candidiasi short period readmit hospit twice recurr klebsiella pneumonia urosepsi one hospit also complic anoth covid infect confirm non reactiv neutral antibodi due sever infect patient requir individu modif immunotherapi howev due recurr final decid discontinu patient also reintroduc hemodialysi therapi infect occur sinc
|
D000086382;D016030
|
T061;T047;T067
|
36,295,530
|
numb knee replac critic complic thought detail analysi neuropath pain function outcom background object numb one complic knee replac kr studi far less complic studi topic without comprehens research numb need design studi includ relev paramet studi investig relationship numb pain neuropath pain impact function emot life function knee materi method knee krs divid anterior six region numb determin pinprick test douleur neuropathiqu dn paindetect questionnair pd q test neuropath pain patient physic emot social status function knee abil assess short form sf western ontario mcmaster univers osteoarthr index womac test relationship numb gender age bilater postop follow time incis measur examin binomi logist regress model appli investig effect age gender bilater incis length postop follow time numb result total patient femal half bilater krs mean age year numb occur frequent l l area region associ gender bilater age weak associ postop follow time posit correl numb neuropath pain found signific relationship numb physic function negat effect emot health signific associ numb effect numb social function statist signific knee function measur womac signific differ found numb group conclus accord result numb consid complic affect social physic life negat impact function outcom knee result show consid statist signific complic numb indirect effect consid patient whose follow paramet normal one year whose symptom resolv
|
D020370;D019645;D009437
|
T061;T184;T047
|
36,295,529
|
perspect challeng dementia research although dementia common devast diseas studi intens year effect diseas modifi treatment found impass new approach import purpos paper provid context current research one clinician perspect regard import challeng field form specif challeng challeng illustr scope problem inher find treatment dementia also specif target foster discuss critic new research one common theme need transform research activ small project individu laboratoriesclin larger multin project clinician research work integr part transform requir collabor research larg corpor regulatorygovernment author general popul well signific financi invest howev cost transform approach small comparison cost dementia
|
D003704
|
T048
|
36,295,528
|
success phakic intraocular len implant usag topic ascorb acid patient reduc corneal endotheli cell densiti aim describ use topic ascorb acid aa patient reduc endotheli cell densiti ecd schedul phakic intraocular len piol implant year old woman present dri eye reduc ecd would like high myopia spheric equival gt correct procedur laser refract surgeri even piol indic reduc ecd mm right eye mm left eye well level dri eye fortun ecd increas mm right eye mm left eye topic aa prescrib one year preoper one month postop concomit improv dri eye level final bilater piol implant perform smooth sign corneal decompens found postop three month postop ecd show satisfactori level mm right eye mm left eye conclus topic aa instil might increas maintain densiti central human corneal endotheli cell hcec even piol implant
|
D054120
|
T074
|
36,295,527
|
epigenet regul obes associ type diabet obes becom widespread epidem condit consid present develop countri lead public health concern dramat increas obes type diabet mellitus tdm relat vascular difficulti caus public health crisi thus imper trend curb understand molecular underpin diseas crucial aid detect even manag thus understand mechan under interact environ lifestyl genet import develop effect strategi manag obes focus find vital role epigenet chang etiolog obes genom epigenom wide approach reveal associ tdm epigenom indic systemat link genet variant environment factor put peopl risk obes present review focus epigenet mechan link obes associ tdm although util epigenet treatment discuss refer certain cancer sever challeng remain address tdm
|
D003924
|
T047
|
36,295,526
|
transcallos pericallos cours anterior cerebr arteri background anterior cerebr arteri aca precommun segment follow postcommun segment anatom send callosomargin arteri cma continu pericallos arteri pcala detail pattern anatom variat pcala need practic reason method retrospect document comput tomographi angiogram male femal result side eleven differ type pcala document type normal origin genu corpus callosum cc type low origin rostrum cc type late origin bodi cc type initi transcallos cours type duplic pcala type azygo pcala type absent pcala cma type aca type cma continu pcala type pcala continu cingular branch type pcala type aca absent cma type tripl pcala ad median arteri cc differ type cma also document type absent cma type cma frontopariet distribut type cma pariet distribut type low origin cma either type cma continu pcala ipsilater combin pcala cma type classifi type p case bilater asymmetri combin anatom pattern pcala cma document addit rare variat found huge fenestr b bihemispher aca case c twist arteri within interhemispher fissur conclus pcala cma anatom divers unpredict therefor document case case basi surgic endovascular approach
|
D020771;D054022
|
T023
|
36,295,525
|
histometr analysi approach reliabl assess histolog bone tissu sampl studi aim evalu grid merz imagej method histometr quantif verifi reliabl defin suitabl base time requir perform thirti histolog sampl maxillari sinus graft xenograft evalu use optic light microscop attach imag captur camera connect microcomput imag digit record tiff imag new bone format evalu use grid merz imagej bland altman analysi use identifi agreement method determin suitabl futur research option time quantif also perform identifi possibl advantag mean valu quantif analysi time grid merz imagej statist signific group p bland altman analysi demonstr concord method due bias next maximum concord addit graphic show scatter point next mean differ insid limit agreement thus demonstr grid merz present reliabl outcom advantag imagej methodolog regard time spent contour area interest
|
D001842
|
T023;T024
|
36,295,524
|
magnesium potenti vortioxetin effect physic perform biolog chang exercis induc stress rat background object vortioxetin vrt relat new select serotonin reuptak inhibitor ssri antidepress serotonin receptor modul approv treatment major depress general anxieti disord depress link psychomotor disengag oxid stress burden decreas blood level brain deriv neurotroph factor bdnf studi perform experiment investig vrt magnesium associ rat endur capac motor behavior blood biolog disturb rat subject forc exercis treadmil test materi method substanc administ oral consecut day follow group control distil water ml g bodi group mg magnesium chlorid mgkg bodi group vrt vrt mgkg bodi group vrtmg vrt mgkg bodi magnesium chlorid mgkg bodi magnesium use posit control substanc known effect treadmil test consequ vrt treatment glucos cortisol bdnf oxid stress biomark superoxid dismutas malondialdehyd glutathion peroxidas lactat dehydrogenas also assess result conclus use vrt result improv motor capac increas rat endur physic effort administr vrt increas serum bdnf level reduc oxid stress rat subject physic effort associ magnesium potenti effect vrt physic perform antioxid activ decreas serum stress marker treadmil test rat
|
D019208;D008274
|
T123;T196;T116
|
36,295,523
|
sex differ cutoff preval sarcopenia among urban korean popul associ metabol syndrom background object studi aim establish threshold valu preval sarcopenia investig associ sarcopenia metabol syndrom urban korean popul materi method studi includ adult underw anthropometr analys bioelectr imped analyz sarcopenia defin class skelet muscl mass index smi within standard deviat sds class ii lt sd smi young popul result low smi threshold level class class ii sarcopenia men women among age group preval rate sarcopenia highest age group year follow adjust possibl confound includ age sex height metabol health behavior factor adjust odd ratio confid interv risk metabol syndrom class class ii sarcopenia compar normal refer sarcopenia strong associ metabol syndrom women men p interact lt threshold valu preval sarcopenia demonstr larg korean urban popul conclus studi identifi sarcopenia associ increas risk metabol syndrom show signific higher women men
|
D055948;D024821
|
T047
|
36,295,522
|
advanc infecti diseas clinic microbiolog covid pandem infecti diseas pose substanti challeng healthcar system associ signific morbid mortal
|
D000086382;D003141
|
T047;T067
|
36,295,521
|
diagnost mock surgic reduct guid crown lengthen techniqu descript case report background object report describ techniqu use diagnost mock crown lengthen surgic guid improv gingiv architectur materi method patient primari concern improv smile due gummi smile short clinic crown clinic evalu surgic crown lengthen accompani maxillari central full coverag singl unit prosthes later incisor veneer recommend diagnost mock place patient maxillari anterior region use soft tissu reduct guid gingivectomi plan gingiv architectur achiev flap reflect proceed ostectomi order obtain appropri alveolar bone crest level use overlay six month ceram crown porcelain veneer provid perman restor result diagnost mock fabric putti guid direct diagnost wax adequ surgic guid crown lengthen procedur diagnost wax use fabric diagnost mock result suggest use crown lengthen surgic guid modifi gingiv architectur sever advantag overlay use aesthet complex case includ provid preview potenti restor outcom allow appropri posit gingiv margin desir alveolar bone crest level crown lengthen procedur serv provision restor surgeri conclus use diagnost mock base diagnost wax surgic guid result success crown lengthen provision restor thus diagnost overlay viabl option surgic guid crown lengthen
|
D016556;D003776
|
T061;T122
|
36,295,520
|
navig guidanc percutan splanchnic nerv radiofrequ neurolysi preliminari result background object describ preliminari result upon applic cube navig system cns comput tomographi ct guid splanchnic nerv radiofrequ neurolysi materi method ct guid splanchnic nerv neurolysi perform five patient case neurolysi perform ct guidanc use cns mean patient age year rang year malefemal technic success paramet neurolysi session complic evalu technic success defin needl posit defin target session paramet includ procedur time number scan cirs report system use complic classif grade result technic success obtain case patient slight correct needl orient necessari mean procedur time min rang min averag four ct scan record five neurolysi session complic materi failur report present studi conclus preliminari result present studi show comput tomographi ct guid splanchnic nerv radiofrequ neurolysi use cns accur time effici percutan procedur prospect compar studi larger patient sampl necessari verif system well draw broader conclus
|
D013153;D014057
|
T060;T023
|
36,295,519
|
evid efficaci high dose vitamin hyperinflamm state moder sever covid patient random clinic trial background object vitamin supplement play key effect lower cytokin storm among covid patient influenc activ renin angiotensin system product angiotensin convert enzym studi conduct explor effect high dose intramuscular vitamin hospit adult infect moder sever sar cov comparison standard care covid protocol materi method two group patient compar prospect random control trial vitamin administ oral group alfacalcidol mcgday intramuscular group cholecalciferol iu one hundr sixteen particip recruit total fifti eight patient group follow egyptian ministri health polici covid manag patient receiv treatment minimum five day result signific differ record length hospit stay versus day need high oxygen non invas mechan ventil versus need mechan ventil versus clinic improv versus occurr sepsi versus monitor laboratori paramet favor high dose vitamin moreov clinic improv signific associ need lowhigh oxygen invasivenon invas mechan ventil mvnimv diabet mortal associ need mv icu admiss atrial fibril chronic obstruct pulmonari diseas asthma occurr secondari infect conclus studi show high dose vitamin consid promis treatment suppress cytokin storm among covid patient associ better clinic improv fewer advers outcom compar low dose vitamin
|
D000086382
|
T047;T067
|
36,295,518
|
delay surgic manag acut type aortic dissect patient recent covid infect post covid bronchopneumonia case report review literatur ever sinc first describ acut type aortic dissect creat difficulti manag recent covid pandem reveal extrapulmonari manifest condit may occur recent report suggest aortic dissect may amongst sinc share common physiopatholog hyper inflammatori syndrom cardiac surgeri cardiopulmonari bypass set covid posit patient carri high risk postop respiratori failur vast major accept manag type aortic dissect requir urgent surgeri central aortic therapi report advoc delay surgeri situat risk aortic ruptur must balanc possibl benefit delay urgent surgeri present case acut type dissect covid associ bronchopneumonia success manag delay surgeri day
|
D000086382;D001996;D000784;D001019
|
T047;T046;T067
|
36,295,517
|
design mrna peptid base vaccin construct emerg multidrug resist citrobact freundii comput base subtract proteom approach background object amp nbsp citrobact freundii c freundii emerg opportunist gram negat bacteria human gastrointestin tract associ nosocomi sever respiratori tract infect also associ pneumonia bloodstream urinari tract infect intrins adapt virul characterist c freundii becom signific sourc diarrheal infect food poison among immun compromis patient newborn impuls usag antibiot adapt virul characterist modul c freundii multidrug resist mdr bacteria convent approach futil mdr c freundii materi method current studi exploit modern comput base vaccin design approach treat infect relat mdr c freundii whole proteom c freundii strain cwh retriev screen pathogen nonhomolog protein six protein shortlist select putat epitop vaccin construct high antigen nonallergen nontox eleven b cell htl tcl epitop select mrna peptid base multi epitop vaccin construct secondari tertiari structur multi epitop vaccin mevc design refin valid result evalu popul coverag mhc mhc ii allel respect dock mevc tlr receptor bind affin kcalmol occur mmgbsa process valid includ codon optim enhanc cai valu gc content immun stimul molecular dynam simul ensur antibodi product upon antigen interact host stabil mevc construct respect conclus interpret propos new strategi combat mdr c freundii vivo vitro trial vaccin valuabl combat mdr pathogen
|
D016971;D040901
|
T007;T091
|
36,295,516
|
idarucizumab dabigatran treat patient acut ischem stroke receiv thrombolyt therapi background object thrombolyt therapi recombin tissu type plasminogen activ rt pa use treat acut ischem stroke dabigatran revers thrombin inhibitor approv stroke prevent patient nonvalvular atrial fibril case thrombolyt therapi administ certain patient idarucizumab treatment evalu effect idarucizumab dabigatran treat patient receiv rt pa materi method includ data nine idarucizumab treat patient riga east univers hospit stroke registri retrospect medic record analysi use nation institut health stroke scale lv nihss score modifi rankin scale mrs admiss discharg evalu neurolog deficit function outcom result analyz data nine patient seven male two femal mean age year median door needl time patient includ receiv idarucizumab rt pa min iqr median lv nihss score iqr admiss iqr discharg intrahospit mortal rate due intracrani hemorrhag complic rt pa conclus studi show idarucizumab antidot dabigatran appear effect safe patient acut ischem stroke furthermor administr idarucizumab slight prolong door needl time howev major case show clinic improv receiv therapi random control trial perform evalu safeti effect idarucizumab acut ischem stroke treatment
|
D000083242;D020521
|
T047
|
36,295,515
|
asept abscess syndrom rheumatoid arthriti patient asept abscess syndrom aa rare potenti life threaten disord numer featur neutrophil dermatos main symptom includ asept abscess like collect intern organ spleen liver lung lack microb bacteria virus parasit exhaust search ineffect antibiot high sensit corticosteroid therapi aa character develop deep inflammatori abscess system symptom weight loss abdomin pain fever leukocytosi may associ inflammatori bowel diseas ibd autoimmun diseas patient studi year old man suffer rheumatoid arthriti ra numer purul abscess mediastinum within subcutan tissu extens surfac joint dorsum hand lesion accompani bone destruct patient treat prednison mg adalimumab result quick reduct inflammatori marker clinic improv well heal absorpt abscess despit covid infect treatment remdesivir prednison adalimumab continu complet resolut lesion aa difficult recogn practition awar condit especi patient ra
|
D000086382;D001172
|
T047;T067
|
36,295,514
|
cyst canal nuck anatomi diagnost treatment rare diagnosi case report adult woman narrat review literatur cyst canal nuck extrem rare femal hydrocel usual occur children also adult women caus patholog canal nuck femal equival male processus vaginali due rariti lack awar among physician cyst canal nuck seldom encount entiti clinic practic common misdiagnos report case cyst canal nuck year old woman present pain swell right groin addit conduct review current avail literatur review give overview anatomi patholog diagnost treatment cyst canal nuck aim review give survey also rais awar cyst canal nuck serv refer medic profession
|
D007264;D003560
|
T023;T029;T190
|
36,295,513
|
silent paus speech indic biomark primari progress aphasia background object recent studi highlight import investig biomark diagnos classifi patient primari progress aphasia ppa even though ongo research pathophysiolog indic field use behavior variabl especi speech deriv factor drawn littl attent relev literatur present studi aim investig possibl util speech deriv indic particular silent paus biomark primari progress aphasia ppa materi method recruit ppa patient healthi control obtain speech sampl base two elicit task ie cooki theft pictur descript ctp patient person narrat diseas onset cours result four main indic deriv speech sampl speech rate articul rate paus frequenc paus durat order investig whether indic could use discrimin four group particip healthi individu three patient subgroup correspond three variant ppa conduct three set analys seri anova two princip compon analys pcas two hierarch cluster analys hcas anova reveal signific differ four subgroup four variabl ctp result robust subsequ pcas hcas accord initi statist comparison reveal speech deriv indic ctp provid clearer classif especi use distinguish non fluent variant healthi particip well two ppa taxonom categori conclus sum argu speech deriv indic especi silent paus could use complementari biomark effici discrimin ppa healthi speaker well three variant diseas
|
D013060;D018888
|
T040;T054;T048
|
36,295,512
|
evalu soft tissu heal implant placement use two differ mouthwash myrrh chlorhexidin glucon random control trial use mouthwash often recommend dental expert dental heal doubl blind random clinic studi conduct evalu efficaci two mouthwash myrrh chlorhexidin glucon postop pain effect tissu dental implant placement patient myrrh group chlorhexidin glucon group soft tissu heal evalu term wound closur soft tissu swell color gingiva week postop decreas chanc error particip show preoper symptom infect commit practic better oral hygien includ studi sampl evalu infiltr inflammatori cell use inflammatori extent inflammatori cellular grade matur collagen osteoblast activ arrang cell detect remodel phase questionnair pertain mouthwash satisfact durat postop pain procedur time stoppag bleed surgic site sensit surgic site given patient chi squar test mann whitney u test use analyz data differ postop surgic swell pain bleed red patient statist signific myrrh chlorhexidin glucon mouthwash group howev acut phase myrrh mouthwash show posit impact process wound heal implant placement small sampl size inabl compar wound heal differ anatom area oral caviti studi limit
|
D000891;D015921
|
T121;T074
|
36,295,511
|
secondari hemophagocyt syndrom patient plasma cell myeloma cns involv treat lenalidomid present extrem rare case report year old multipl myeloma patient central nervous system involv secondari hemophagocyt lymphohistiocytosi hlh observ hlh presum trigger immunomodulatori drug lenalidomid hlh frequent misdiagnos underdiagnos hlh requir immedi treatment report emphas need consid hlh differenti diagnosi condit patient receiv chemotherapi rapid deterior infecti etiolog exclud furthermor discuss pathogenesi hlh particular emphasi drug affect immun system well possibl therapeut strategi
|
D051359;D009101;D016609
|
T047;T191
|
36,295,510
|
epileptogenesi tumorigenesi glioblastoma relationship epilepsi report patient glioblastoma gbm import role natur histori tumor patient life qualiti although gbm less epileptogen lower grade glioma seizur usual difficult control common antiseizur medic drug resist found case recent studi suggest seizur onset gbm could possibl favor independ prognost factor patient moreov grow bodi evid show mani molecular mechan influenc epileptogenesi often regul gbm growth invas sometim favor counteract tumor respect better character player includ glutam aminobutyr acid aquaporin hypoxia activ molecul howev current avail data molecular basi epileptogenesi tumorigenesi relationship incomplet discord research urgent need topic
|
D005909;D001932;D020346
|
T123;T191;T116
|
36,295,509
|
identifi factor predict kidney graft surviv chile use elast net regular cox regress background object develop predict statist model identifi donor recipi characterist relat kidney graft surviv chilean popul given larg number potenti predictor relat sampl size implement autom variabl select mechan could revis futur studi nation data collect materi method retrospect multicent studi conduct analyz data adult kidney transplant recipi adult donor best knowledg largest kidney transplant databas date chile procedur base cross valid regular cox regress use elast net penalti appli object identifi predictor death censor graft failur hazard ratio estim adjust multivari cox regress select predictor result seven variabl associ risk death censor graft failur four donor age hr ci male sex hr ci histori hypertens hr ci histori diabet hr ci two recipi year dialysi log transform hr ci histori previous solid organ transplant hr ci one transplant number hla mismatch hr ci latter consid patient priorit deceas kidney alloc chile conclus risk model kidney graft failur develop train chilean popul provid object criteria use improv effici deceas kidney alloc
|
D006085;D016030
|
T061;T042
|
36,295,508
|
potenti associ subclin hypothyroid childhood migrain background object migrain caus genet suscept trigger environment well biolog factor also link mani somat comorbid includ clinic subclin hypothyroid aim estim potenti associ subclin hypothyroid sch migrain children tertiari hospit materi method use case control strategi children adolesc assign two equal group case group patient migrain patient control group patient without migrain clinic biochem paramet tsh ft compar group use statist analysi result thyroid function comparison group show higher tsh normal ft among children migrain headach compar control group mean frequent sch case among migrain group relat control vs p lt obes overweight frequent among patient migrain control group vs respect overweightobes patient migrain sch overt hypothyroid compar sch overt hypothyroid among normal bodi weight migrain patient p lt signific differ preval nodular goiter patient migrain control found conclus base result subclin hypothyroid signific link childhood migrain obes overweight frequent among patient migrain therefor may logic test thyroid function migraineur children especi high bmi studi recommend discov mechan associ children
|
D007037;D008881
|
T047
|
36,295,507
|
misfit implant support zirconia tzp cad cam framework compar non zirconia framework systemat review object aim studi systemat review overal outcom studi compar misfit yttria stabil zirconia tzp cad cam implant support framework framework fabric materi techniqu method electron literatur search english literatur perform use googl scholar scopus web scienc medlin ovid embas pubm use predetermin inclus criteria specif term util conduct search incept respect databas may search strategi appli data extract result analyz focus question misfit implant support zirconia cad cam framework lower non tzp implant support fix restor result eleven articl includ qualit assess critic apprais review includ studi tzp cad cam implant support framework compar titanium ti ni cr co cr peek high densiti polym cast cad cam framework studi use scan electron microscopi one screw test digit optic microscopi virtual assess replica techniqu analyz misfit framework six studi show compar misfit among tzp cad cam framework control three studi show higher misfit tzp cad cam framework wherea two studi report lower misfit tzp cad cam implant framework compar control conclus tzp cad cam implant support framework compar misfit implant support framework howev due heterogen methodolog includ studi overal numer misfit framework assess review studi debat
|
D014025;D015040
|
T196
|
36,295,506
|
thyroid bed schwannoma mimick thyroid neoplasm challeng diagnosi report case literatur review schwannoma also call neurinoma rare benign tumor neural cell develop sheath nervous structur sever district although frequent site cranial nerv rare case show neck schwannoma thyroid parenchyma case thyroid bed schwannoma mimick thyroid gland lesion anecdot
|
D013964;D009442
|
T191
|
36,295,505
|
crohn diseas jejun arteri aneurysm report first case review literatur background object jejun arteri ja ileal arteri ia aneurysm constitut less viscer arteri aneurysm vaa carri risk ruptur high mortal though mani etiolog report literatur mention exist causal associ aneurysm inflammatori bowel diseas ibd present first case ja aneurysm relat crohn diseas cd togeth review literatur materi method year old male present cd intestin relaps incident find comput tomographi enterographi cte mm appar intact ja pseudoaneurysm aris first second jejun branch underw coil embol follow small bowel resect unev outcom also includ review literatur ja ia aneurysm analyz report publish pubm scopus juli result manuscript case ja ia aneurysm patient identifi among case avail data present acut ruptur describ non ruptur ja ia aneurysm respect median size rang mm atherosclerosi infect vasculitidesconnect tissu disord repres main caus mention mean age year male patient one third patient asymptomat overal treatment indic patient surgeri endovascular procedur perform case respect technic success rate endovascular treatment evt mortal rate higher ruptur group conclus prompt treatment accomplish case grant success outcom ja ia aneurysm includ among local complic ibd consid high potenti ruptur regardless size low threshold endovascular surgic treatment appli
|
D003424;D000783;D057510
|
T061;T047;T046;T190
|
36,295,504
|
hepat arteri infus chemotherapi oxaliplatin plus raltitrex altern option advanc hepatocellular carcinoma patient failur unsuit transarteri chemoembol background object assess efficaci safeti hepat arteri infus chemotherapi haic oxaliplatin plus raltitrex haicrox altern treatment option advanc hepatocellular carcinoma hcc patient inelig fail transarteri chemoembol tace treatment materi method juli novemb total hcc patient enrol receiv haic oxaliplatin plus raltitrex overal surviv os time progress ttp primari secondari endpoint respect tumor respons assess modifi respons evalu criteria solid tumor mrecist advers event investig use common terminolog criteria advers event version ctcae result median os ttp month confid interv ci month ci respect mean multivari analysi anti program cell death protein anti pd immunotherapi found independ prognost factor better surviv patient experienc toxic relat death thrombocytopenia alanin aminotransferas alt aspart aminotransferas ast elev common toxic grade higher advers event relat haicrox observ conclus haicrox show valuabl efficaci toler toxic advanc hcc patient progress tace inelig tace haicrox promis treatment advanc stage hcc patient tace failur inelig
|
D006528;D016461;D008113
|
T061;T191
|
36,295,503
|
extern apic root resorpt orthodont patient practic combat sport case control observ pilot studi orthodont treatment could lead undesir effect extern apic root resorpt earr moreov trauma face teeth predispos earr hand practic combat sport result increas maxillofaci injuri consequ object determin statist signific differ earr patient undergo fix orthodont treatment practic combat sport control null hypothesi differ earr patient undergo orthodont treatment practic combat sport patient treatment practic combat sport observ descript prospect case control pilot studi design expos group consist patient practic combat sport wherea control group conform patient practic combat sport without previous histori facial trauma without face trauma orthodont treatment earr maxillari mandibular anterior teeth measur use cone beam comput tomographi cbct cbct scan obtain patient prior begin orthodont treatment year later end follow maxillari right central later incisor expos group earr signific higher homolog teeth control group p lt consequ patient treat orthodont practic combat sport could suscept earr
|
D012391
|
T047
|
36,295,502
|
effect week exercis program function fit oxid stress salivari cortisol level elder subject background object age biolog irrevers process character physiolog alter result progress declin biolog function decreas resist adapt stress increas diseas suscept declin function fit imbal pro antioxid capac andor hormon dysregul advers impact physic capac emot status overal qualiti life especi within elder popul hand regular physic activ consid effect strategi prevent reduc chang associ primari age concurr chronic diseas slow age relat physic degener howev still limit evid base inform regard intens interv effect intervent physic function older adult thus aim studi assess effect week regular multimod exercis program function fit oxid stress salivari cortisol level self perceiv qualiti life group eighteen physic activ elder subject mean age year materi method set anthropometr physic measur grip strength chair sit stand sit reach back scratch assess function fit perform evalu moreov biochem marker deriv reactiv oxygen metabolit rom biolog antioxid potenti bap test salivari cortisol level euroqol dimens level euroqol l self perceiv questionnair qualiti life measur intervent program measur normal distribut assess dagostino pearson omnibus normal test student test use evalu differ paramet measur baselin week physic program result result show age tailor structur intervent exercis program h per session twice per week week effect improv flexibl biomechan paramet muscl strength dynam balanc fit compon key perform daili task independ moreov biochem analys demonstr propos intervent program benefici effect balanc plasma ros product neutral conclus result confirm benefit regular physic activ older adult result improv physic strength flexibl function fit paramet regul anti pro oxid activ cortisol stress hormon level
|
D010809;D006854
|
T078;T121;T125;T109
|
36,295,501
|
risk assess periop respiratori advers event valid cold score children upper respiratori tract infect background object children greater risk upper respiratori tract infect urti pose higher risk periop respiratori advers event prae adult purpos studi valid cold score pre anesthet risk assess tool predict possibl prae materi method children age year undergo elect surgeri retrospect includ logist regress analysi area receiv oper characterist roc curv auc use estim abil cold score predict prae propens match comparison evalu use cut valu roc curv result among children children recent urti case prae report age current symptom cold score found signific variabl predict prae roc curv valu p auc cut valu cold score calcul propens match comparison reveal everi compon cold contribut higher cold score group addit higher cold score younger age current urti symptom found signific risk factor prae conclus studi valid predict power cold score risk assess tool children urti undergo elect surgeri general anesthesia
|
D003139;D000777
|
T039;T184;T121;T033;T047
|
36,295,500
|
effect blocker therapi level solubl st protein pediatr dilat cardiomyopathi background object prognosi kid pediatr dilat cardiomyopathi pdcm urgent need identifi high risk patient studi aim determin associ level solubl suppress tumorigen sst medic therapi blocker inhibitor risk advers event pdcm materi method total patient pdcm enrol admiss center china follow advers event death cardiac transplant heart failur relat rehospit base median sst level usag blocker inhibitor patient divid four group cox proport hazard model use assess risk incid advers event result median level sst ngml patient receiv blocker treatment median follow day advers event occur compar patient sst lt median without blocker patient sst median without blocker hr ci follow sst median use blocker highest risk advers event hazard ratio hr confid interv ci howev signific associ observ patient sst lt median use blocker associ consist across differ subgroup conclus higher level sst associ higher risk advers event patient pdcm blocker treatment children high level sst effect avoid advers event
|
D002311;D006333
|
T047;T046
|
36,295,499
|
patient center therapi obstruct sleep apnea review obstruct sleep apnea osa one common sleep problem defin cessat decreas airflow despit breath effort known relat multipl advers health consequ posit airway pressur pap consid effect treatment wide use various mode pap emerg treatment option avail multidisciplinari approach understand divers phenotyp osa share decis make necessari success osa treatment patient center care essenti modal support patient care util patient osa help improv outcom treatment adher patient satisfact
|
D020181
|
T047
|
36,295,498
|
effect vitamin bone regener review background object vitamin vit known role skelet system vit defici also wide research effect heal fractur bone defect osseointegr implant literatur studi investig effect dietari supplement vit reduc vit defici increas serum level vitamin take time therefor attempt made combat effect vit defici topic applic aim articl conduct review exist bibliograph data investig effect vit bone regener materi method order carri review electron search made sever databas articl found select analyz result vitro studi result demonstr vit high therapeut potenti enhanc differenti stem cell osteoblast human anim studi conduct use various method reveal vit posit influenc process bone regener conclus overal result research show inde vit benefici bone regener howev studi impli thorough research still need find effect mode administr dose need order achiev desir effect
|
D014808;D050723
|
T047;T037
|
36,295,497
|
relationship voic qualiti obstruct sleep apnea sever cumul percentag time spent satur nineti percent voic analysi obstruct sleep apnea patient background object apnea hypopnea index import criterion determin sever obstruct sleep apnea osa percentag total number time oxygen satur measur polysomnographi ct import determin sever hypoxemia hypoxemia increas inflamm also increas osa inflamm respiratori tract may affect phonat aim determin effect degre osa ct phonat materi method patient age year divid four group normal mild moder sever osa patient ask say vowel voic record maximum phonat time mpt record use praat voic analysi program jitter shimmer harmon nois ratio hnr f valu obtain result seventi two patient includ vowel sound signific differ jitter shimmer hnr measur st th group p lt p lt p lt respect correl ct shimmer hnr valu p lt p lt respect vowel sound signific differ f valu st group nd th group p lt p lt respect jitter shimmer hnr measur st th group p lt p lt p lt respect correl ct shimmer hnr valu p lt p lt respect differ signific mpt st group rd th group p lt p lt respect conclus glottic phonat affect especi patient whose ahi score voic qualiti decreas degre osa increas increas ct associ worsen voic use predictor evalu voic disord futur
|
D014833;D020181
|
T047;T080
|
36,295,496
|
psychoanalyt deriv brief psychotherapeut approach treatment major depress monotherapi studi year short term psychodynam therapi stpp broad research order evalu efficaci treatment major psychiatr disord particular consist number studi focus assess clinic outcom princip psychodynam techniqu treat depress disord conduct narrat review aim evalu efficaci stpp monotherapi major depress disord assess possibl featur may correl clinic use databas search pubm ovid scopus psycinfo cochran librari incept juli research underlin stpp monotherapi particular effect moder sever depress prevent depress relaps moreov case case evalu efficaci perform consid stpp treatment major depress comorbid psychiatr condit although key point emerg scientif evid stpp better studi long term perspect research need defin clinic scenario stpp consid first line approach monotherapi major depress disord compar medic type psychotherapi
|
D003865;D011614;D064889
|
T061;T048
|
36,295,495
|
cutan permeat percutan appli glucocorticoid use plant base anion phospholipid hydrogen veget oil preliminari studi purpos import corticosteroid use therapeut concentr reduc much possibl mitig potenti advers event side effect preliminari studi compar permeat deliveri corticosteroid hydrocortison supplement topic cream contain anion polar phospholipid app hydrogen veget oil triglycerid versus market lead hydrocortison miner hydrocarbon base skin cream method use franz diffus cell method cadaver skin permeat hydrocortison supplement cream contain app test prepar compar commerci avail hydrocortison cream control prepar princip app test prepar phosphatidylinositol phosphatidylserin phosphatidylglycerol permeat determin h time interv result permeat valu hydrocortison supplement app cream test prepar compar high ngcm h ngcm h contrast hydrocortison cream control prepar valu ngcm h ngcm h permeat skin cream increas signific h compar app test prepar control prepar p lt translat respect fold greater fold greater penetr test prepar app cream hydrocortison cream h h time point conclus preliminari studi demonstr enhanc permeat hydrocortison appli topic skin app skin cream vehicl enhanc permeat suggest potenti use app technolog deliv therapeut effect hydrocortison treatment skin mark reduc concentr steroid app technolog may offer improv approach treatment dermatos associ inflammatori diseas condit requir prolong topic corticosteroid therapi
|
D005938;D006854
|
T125;T121;T039;T109
|
36,295,494
|
quantit assess liver impair chronic viral hepat tc tc mebrofenin noninvas attempt stage viral hepat associ liver fibrosi background object chronic viral hepat b c infect one lead caus chronic liver impair result liver fibrosi liver cirrhosi earli diagnosi accur liver fibrosi stage lead proper diagnosi thus tailor correct treatment invas noninvas techniqu use diagnosi stage chronic liver impair techniqu includ liver biopsi multipl serolog marker either singl test combin panel imag examin ultrasound magnet reson elastographi nuclear medicin probe may also employ stage liver fibrosi although literatur scarc report purpos studi investig whether dynam liver scintigraphi tc tc mebrofenin valu stage grade chronic liver damag materi method prospect enrol patient chronic viral hepat b c infect refer liver biopsi patient underw dynam liver scintigraphi mtc mebrofenin prior liver biopsi dynam liver scintigraphi perform immedi intraven tracer inject min scan time multipl scintigraphi paramet calcul whole liver lobe focal area time peak ttp min peak ratio peak whole lobe focal area slope index slope liver biopsi took place short imag result found mani dynam scintigraph paramet posit negat associ differ stage liver fibrosi main paramet show valu ratio min peak dynam curv peakdex ratio liver clearanc correct bodi surfac area liver area lclm dm minm dm conclus present studi prove conduct dynam liver scintigraphi tc tc mebrofenin potenti valu stage liver fibrosi benefit method includ whole liver imag direct imag liver function provid advantag present use quantit imag modal
|
D008107;D006525
|
T033;T047
|
36,295,493
|
use ten pain control updat state evid transcutan electr nerv stimul ten non pharmacolog intervent use treatment acut chronic pain condit first clinic studi ten publish year ago effect paramet stimul unclear clinic trial design infanc last two decad better understand mechan under ten efficaci led develop adequ dose improv outcom measur util continu uncertainti clinic efficaci ten allevi pain despit year research relat qualiti clinic trial includ systemat review summari evid includ trial pain primari outcom outcom rate posit negat undecid u equival effect intervent comparison review appear improv advers event paramet report import stimul intens document critic therapeut success examin outcom beyond rest pain analges toler identif ten respond remain less studi area research literatur review support conclus ten may efficaci varieti acut chronic pain condit although magnitud effect remain uncertain due low qualiti exist literatur order provid inform individu pain clinician treat pain suggest resourc research target larger high qualiti clinic trial includ adequ ten dose adequ time outcom monitor risk bias systemat review meta analys focus area suffici strong clinic trial result adequ sampl size
|
D004561;D059350
|
T061;T184;T047
|
36,295,492
|
serum procalcitonin level newli diagnos hodgkin lymphoma correl inflammatori biomark background object procalcitonin pct use biomark diagnosi sepsi inflammatori marker elev patient hodgkin lymphoma hl yet ongo infect rare coexist diagnosi pct level might help differenti bacteri diseas relat inflamm materi method evalu serum pct level inflamm marker newli diagnos hl patient valu lt ngml consid normal ngml detect lt ngml undetect valu ngl consid elev result among patient b symptom elev erythrocyt sediment rate esr elev c reactiv protein crp median mgl rang pct level normal patient undetect detect median valu lt ngml rang lt elev pct record two patient patient pct lt ngml signific lower median crp rang compar patient pct ngml median crp mgl rang almost patient detect pct elev crp conclus first studi show inflamm character hl associ pct elev although crp level elev patient normal pct level may rule possibl occult infect thus prevent extens evalu may delay treatment initi
|
D000077740;D006689
|
T123;T191;T116
|
36,295,491
|
loss express antiangiogen protein fkbpl endometrioid endometri carcinoma implic clinic practic background object fk bind protein like fkbpl member immunophilin famili anti angiogen effect capabl inhibit migrat endotheli cell blood vessel format role inhibitor tumor growth angiogenesi previous shown studi breast ovarian cancer role fkbpl angiogenesi growth carcinogenesi endometrioid endometri carcinoma eec still larg unknown aim studi examin express fkbpl eec benign endometri hyperplasia beh correl express vascular endotheli factor vegf estrogen receptor alpha er materi method specimen patient eec patient beh well histolog clinic demograph data obtain clinic hospit centr zemun belgrad serbia year period immunohistochem stain tissu perform fkbpl vegf er slide analyz blind two pathologist measur intens fkbpl vegf express use allr score determin level er express result immunohistochem analysi show moder high intens fkbpl express n sampl beh low express n case eec fkbpl stain show high posit predict valu high negat predict valu malign diagnosi differ fkbpl express eec beh statist signific p lt show decreas intens loss express malign tissu endometrium fkbpl express posit correl er express intens percentag high allr score valu negat correl express vegf p lt conclus fkbpl protein express demonstr signific decreas fkbpl eec comparison beh tissu high predict valu malign fkbpl might emerg signific protein antiangiogen antineoplast effect show great promis diagnost therapeut applic therapeut deriv gynecolog oncolog
|
D018269;D016889
|
T191
|
36,295,490
|
clear cell renal cell carcinoma diagnost therapeut difficulti case report literatur review nephroblastoma common kidney tumour children constitut case although renal cell carcinoma rcc second common kidney malign children constitut case current basi children rcc treatment umbrella protocol siop rtsg due rare diagnosi neoplasm children difficult case treatment base experi adult patient rcc nephrectomi improv prognosi usual perform first step treatment acut kidney injuri secondari urolithiasi patient nephrectomi due rcc uniqu serious complic studi design present case year old boy metastat clear cell renal cell carcinoma ccrcc right kidney acut renal failur left kidney secondari uric acid nephrolithiasi partial regress spread ccrcc month treatment sunitinib follow progress observ satisfactori effect toler nivolumab observ later comorbid acut kidney injuri nephrolithiasi ccrcc nephrectomi children uniqu drug use treatment clear cell carcinoma adult sunitinib nivolumab also use children ccrcc
|
D002292;D007680;D058186;D053040
|
T047;T191;T037
|
36,295,489
|
integr radiosensit gene signatur improv glioma outcom radiotherapi respons predict respons radiotherapi rt glioma vari wide patient necessari identifi glioma associ radiosensit gene signatur clinic stratifi patient benefit adjuv radiotherapi glioma surgeri method chines glioma genom atlas cgga cancer genom atlas tcga glioma patient dataset use valid predict potenti two publish biomark radiosensit index rsi gene signatur gs adjust marker characterist glioma integr four new glioma associ radiosensit predict index base rsi gs cox analysi least absolut shrinkag select oper lasso regress analysi receiv oper characterist roc curv integr discrimin improv idi net reclassif improv nri use compar radiosensit predict abil six gene signatur subgroup analysi use evalu discrimin capac gene signatur identifi radiosensit patient nomogram built improv histolog grade system gene ontolog go analysi gene set enrich analysi gsea use explor relat biolog process result valid compar predict potenti two publish predict index auc area gs higher rsi base rsi gs integr four new glioma associ radiosensit predict index pi pi pi pi among gene radiosensit predict index pi show promis predict perform discrimin capac examin nomogram creat clinic featur pi reveal predict capac superior tradit classif system c index vs p go analysi gsea show tumor high pi score correl various aspect malign glioma conclus glioma associ radiosensit gene signatur pi promis radiosensit predict biomark guid effect person radiotherapi glioma
|
D005910
|
T191
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.